SEC Form 4 · accession 0001209191-16-114243
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J Meyer
Director
Period of report
Apr 14, 2016
Accepted (ET)
Apr 14, 2016 · 6:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 14, 2016 | M | 1,500 | $13.57 | A | 19,500 | D | |
| Common Stock | Apr 14, 2016 | M | 10,500 | $3.63 | A | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.57 | Apr 14, 2016 | M | 1,500 | D | — | Aug 6, 2024 | Common Stock | 1,500 | 8,000 | D |
| Stock Option (right to buy)F2 | $3.63 | Apr 14, 2016 | M | 10,500 | D | — | May 13, 2023 | Common Stock | 10,500 | 40,000 | D |
Explanation of responses
- F1One third of the shares subject to the option shall vest on August 7, 2015 and the remainder shall vest in 24 equal monthly installments thereafter until fully vested and exercisable on August 7, 2017.
- F2One third of the shares subject to the option shall vest on May 14, 2014 and the remainder shall vest in 24 equal monthly installments thereafter until fully vested and exercisable on May 14, 2016.